Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shentongzhuyu decoction (身痛逐瘀汤, Shēn tòng zhú yū tāng) is a classic Traditional Chinese Medicine (TCM) formula first recorded in the "Correction of Errors in Medical Works" (Yi Lin Gai Cuo) by Wang Qingren. It is specifically designed to treat pain throughout the body caused by blood stasis and wind-dampness. The decoction is a complex mixture of herbs, including *Gentiana macrophylla*, *Ligusticum chuanxiong*, *Prunus persica*, and *Carthamus tinctorius*, which are believed to work synergistically to activate blood circulation, remove stasis, and unblock the meridians. In modern clinical research, it is primarily investigated for its potential in treating ankylosing spondylitis, rheumatoid arthritis, and various forms of neuralgia or musculoskeletal pain. A clinical study sponsored by The First Affiliated Hospital of Heilongjiang Chinese Medicine College compared its efficacy to leflunomide in patients with ankylosing spondylitis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shentongzhuyu decoction.